These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6788660)

  • 21. Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII.
    Farrugia A
    Australas Biotechnol; 1993; 3(1):16-20. PubMed ID: 7763537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?
    Berntorp E
    Haematologica; 2003 Jun; 88(6):EREP03. PubMed ID: 12826529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Specific hemotherapy].
    Stich W
    Internist (Berl); 1969 Feb; 10(2):52-8. PubMed ID: 4188581
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group.
    Transfus Med; 1994 Dec; 4(4):251-68. PubMed ID: 7889138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion of factor VIII for surgery and major bleeding.
    Hay CR; Doughty HI; Savidge GF
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of low plasma haptoglobin values found in hemophilia A patients on prophylactic treatment with factor VIII concentrates - a sign of hemolysis?
    Egberg N; Blombäck M
    Thromb Haemost; 1981 Aug; 46(2):554-7. PubMed ID: 6795743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood component therapy in neonatal medicine.
    Lenes BA; Sacher RA
    Clin Lab Med; 1981 Jun; 1(2):285-309. PubMed ID: 6809397
    [No Abstract]   [Full Text] [Related]  

  • 30. Update on transfusion medicine.
    Shander A; Goodnough LT
    Pharmacotherapy; 2007 Sep; 27(9 Pt 2):57S-68S. PubMed ID: 17723109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal use of blood components and derivatives.
    Walter WJ; Oberman HA
    Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgical orthopedic correction of hemophilic hemarthrosis at Ramathibodi Hospital.
    Isarangkura P; Keorochana S; Chuansumrit A; Jitpraphai C; Mahaphan W; Hathirat P; Chiewsilp P; Prachathumrong P; Pintadit P; Panthangkura W
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():253-5. PubMed ID: 7886589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood transfusion: merits of component therapy. II. The clinical use of plasma and plasma components.
    Buchholz DH
    J Pediatr; 1974 Feb; 84(2):165-72. PubMed ID: 4589841
    [No Abstract]   [Full Text] [Related]  

  • 34. Component therapy.
    Schmidt PJ
    Int Anesthesiol Clin; 1982; 20(4):23-43. PubMed ID: 6816740
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Factor VIII preparation produced by recombinant DNA-technology is approved in Norway].
    Briseid G; Arntzen FC
    Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1849-51. PubMed ID: 7638835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estimation of the blood donation necessary for self-sufficiency of blood products].
    Pinto V; Hernández Mejía R; Cueto A
    Sangre (Barc); 1999 Feb; 44(1):38-43. PubMed ID: 10323095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.
    Morfini M; Messori A; Longo G
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S11-4. PubMed ID: 8735791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractionation of plasma with polyethylene glycol.
    Polson A; Ruiz-Bravo C
    Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of plasma derivatives for clinical use.
    Tullis JL
    Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.